rom-2 Antibody

RRM2 Antibody: Characteristics and Applications

The CPTC-RRM2-2 antibody, developed by the Clinical Proteomics Technologies for Cancer (CPTC), specifically targets human RRM2 (ribonucleotide reductase M2), a subunit critical for DNA synthesis. Below is a detailed breakdown of its properties:

Key Features:

• Specificity: Recognizes RRM2, a component of the ribonucleotide reductase enzyme, which catalyzes the conversion of ribonucleotides to deoxyribonucleotides.

• Applications: Used in cancer research to study DNA replication and repair mechanisms.

• Availability: Available for non-profit research; hybridoma cells are not provided .

ROM2 Gene: Context and Relevance

While RRM2 antibodies are well-documented, ROM2 (a gene in Cryptococcus neoformans and yeast) has distinct roles unrelated to antibody development:

• Function:

  • In C. neoformans: Regulates cell morphogenesis, actin/microtubule organization, and cytokinesis under stress .

  • In S. cerevisiae: Acts as a GTPase-activating protein (GAP) for Rho1, influencing cell wall integrity and fatty acid synthesis .

• Pathways:

  • Interacts with the cell wall integrity pathway (e.g., Rho1-Pkc1-Slt2 MAPK cascade) .

  • Modulates sphingolipid metabolism and membrane composition .

No antibodies targeting ROM2 are identified in the provided sources.

Research Gaps and Considerations

• Nomenclature Confusion: "Rom-2" may refer to distinct entities (e.g., RRM2 vs. ROM2). Clarification is critical for reproducibility.

• Clinical Relevance: RRM2 antibodies hold potential in cancer diagnostics/therapeutics, while ROM2 remains a model organism gene with limited translational data.

• Methodological Limitations:

  • RRM2 antibody studies focus on basic research; clinical validation is sparse.

  • ROM2’s role in fungal pathogenesis or human disease remains underexplored .